ADVANCED CANCER
Clinical trials for ADVANCED CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED CANCER trials appear
Sign up with your email to follow new studies for ADVANCED CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human test of new Cancer-Fighting antibody begins
Disease control TerminatedThis is an early-stage study to test the safety and find the right dose of a new drug called BGB-B3227 for people with advanced or metastatic solid tumors. The drug will be tested both by itself and in combination with another cancer drug, tislelizumab. The main goals are to see …
Matched conditions: ADVANCED CANCER
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New cancer drug enters first human trials
Disease control TerminatedThis was the first human study testing an experimental drug called DS-9606a in people with advanced solid tumors, including ovarian, lung, and pancreatic cancers. The main goals were to find a safe dose and understand how the body processes the drug. The study was terminated earl…
Matched conditions: ADVANCED CANCER
Phase: PHASE1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Early cancer drug trial halted after testing in 92 patients
Disease control TerminatedThis early-stage study aimed to find a safe dose for a new experimental drug called BMS-986258, testing it alone and combined with an existing immunotherapy (nivolumab) in people with advanced cancers. It enrolled 92 participants with specific advanced tumors who had already trie…
Matched conditions: ADVANCED CANCER
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New cancer drug enters human testing for advanced tumors
Disease control TerminatedThis first-in-human study tested a new cancer drug called PHN-010 in patients with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check the drug's safety, determine the right dose, and see if it could shrink tumors. The trial incl…
Matched conditions: ADVANCED CANCER
Phase: PHASE1 • Sponsor: Pheon Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC